Skip to main content
. 2022 Sep 26;27(11):905–e848. doi: 10.1093/oncolo/oyac174
Drug 1
Generic/working name Epacadostat
Company name Incyte Corporation
Drug type Small molecule
Drug class IDO1 inhibitor
Dose 100
Unit mg
Route Oral (po)
Schedule of administration Twice-daily (bid)
Drug 2
Generic/working name Pembrolizumab
Company name Merck & Co., Inc.
Drug type Antibody
Drug class Immunotherapy
Dose 200
Unit mg
Route Intravenous
Schedule of administration Every 3 weeks for up to 35 infusions
Drug 3
Generic/working name Cyclophosphamide
Company name Generic
Drug type Small molecule
Drug class Alkylating agent
Dose 50
Unit mg
Route Oral
Schedule of administration Daily